Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus …

YS Alsowaida, G Benitez, K Bin Saleh, TA Almangour… - Antibiotics, 2022 - mdpi.com
(1) Background: Ceftriaxone is a potential alternative for the treatment of methicillin-
susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) in acute care and …

Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis

K Eljaaly, H Wali, A Basilim, A Alharbi… - International journal of …, 2019 - Elsevier
Ceftriaxone is an empirical antibiotic commonly used to treat pneumonia. However, its use to
treat infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) is …

Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus …

ZA Yetmar, RB Khodadadi, JR Go… - European Journal of …, 2023 - Springer
Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia is associated with poor
outcomes. Ceftriaxone offers logistical advantages over other standard therapies, though in …

Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches

B Lee, I Tam, B Weigel IV, JL Breeze… - Journal of …, 2015 - academic.oup.com
Objectives β-Lactam antibiotics are commonly used in outpatient parenteral antimicrobial
therapy (OPAT), but data regarding outcomes of long-term therapy are limited. The purpose …

Outcomes of Outpatient Parenteral Antimicrobial Therapy With Ceftriaxone for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections—A Single …

Y Hamad, L Connor, TC Bailey… - Open Forum Infectious …, 2020 - academic.oup.com
Background Staphylococcus aureus bloodstream infections (BSIs) are associated with
significant morbidity and mortality. Ceftriaxone is convenient for outpatient parenteral …

Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta …

ZA Yetmar, S Razi, T Nayfeh, DJ Gerberi… - International Journal of …, 2022 - Elsevier
Optimal therapy for methicillin-susceptible Staphylococcus aureus (MSSA) infections is
unclear. Current standard of care consists of antistaphylococcal antibiotics (ASAs) such as …

A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia in a Tertiary Care VA Medical Center

DR Carr, U Stiefel, RA Bonomo… - Open Forum …, 2018 - academic.oup.com
Background Cefazolin and ceftriaxone are frequently used to treat methicillin-susceptible
Staphylococcus aureus (MSSA) bacteremia, especially in the realm of outpatient parenteral …

Clinical outcomes of an innovative cefazolin delivery program for MSSA infections in OPAT

L Herrera-Hidalgo, R Luque-Márquez… - Journal of Clinical …, 2022 - mdpi.com
Cefazolin is a recommended treatment for methicillin-susceptible Staphylococcus aureus
(MSSA) infections that has been successfully used in outpatient parenteral antibiotic therapy …

Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A …

MM Kamfose, FG Muriithi, T Knight, D Lasserson… - Antibiotics, 2020 - mdpi.com
Background: Methicillin-susceptible Staphylococcus aureus (MSSA) is a common pathogen
associated with a range of clinically important infections. MSSA can cause deep-seated …

Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections: A Noninferiority Retrospective Cohort …

A Ganguly, C de la Flor, K Alvarez… - Annals of …, 2023 - journals.sagepub.com
Background: Antistaphylococcal penicillins and cefazolin are the treatments of choice for
methicillin-susceptible Staphylococcus aureus (MSSA) infections, requiring multiple doses …